- Report
- May 2022
- 256 Pages
Global
From €3145EUR$3,456USD£2,696GBP
- Report
- March 2022
- 180 Pages
Global
From €3145EUR$3,456USD£2,696GBP
- Book
- August 2023
- 464 Pages
- Book
- July 2023
- 512 Pages
- Book
- March 2023
- 544 Pages
- Book
- October 2022
- 432 Pages
- Book
- March 2022
- 896 Pages
- Book
- January 2022
- 400 Pages
- Book
- May 2021
- 560 Pages
- Book
- April 2021
- 528 Pages
- Book
- January 2020
- 536 Pages
- Book
- January 2020
- 424 Pages
- Book
- November 2017
- 628 Pages
- Book
- November 2013
- 744 Pages
- Book
- February 2024
- 496 Pages
- Book
- July 2023
- 512 Pages

Downstream Processing (DSP) is a biotechnology process used to purify and concentrate biopharmaceuticals, such as proteins, antibodies, and enzymes. It is a critical step in the production of biopharmaceuticals, as it ensures the quality and safety of the final product. DSP involves a series of steps, such as filtration, chromatography, and ultrafiltration, to separate and purify the desired product from the rest of the components. The process is highly complex and requires specialized equipment and expertise.
The DSP market is growing rapidly, driven by the increasing demand for biopharmaceuticals and the need for efficient and cost-effective production processes. The market is expected to continue to grow in the coming years, driven by technological advancements and the increasing demand for biopharmaceuticals.
Some of the major companies in the DSP market include Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Sartorius AG, and Pall Corporation. Show Less Read more